Immunotherapy with concurrent subcutaneous GM-CSF, low-dose IL-2 and IFN-α in patients with progressive metastatic renal cell carcinoma

The purpose of the study was to determine toxicity, efficacy and immunologic effects of concurrent subcutaneous injections of low-dose interleukin-2 (LD-IL-2), granulocyte–monocyte colony-stimulating factor (GM-CSF) and interferon-α 2b (IFNα) in progressive metastatic renal cell carcinoma. In a mult...

Full description

Saved in:

Bibliographic Details
Main Authors:	Verra, N, Jansen, R, Groenewegen, G, Mallo, H, Kersten, M J, Bex, A, Vyth-Dreese, F A, Sein, J, van de Kasteele, W, Nooijen, W J, de Waal, M, Horenblas, S, de Gast, G C
Format:	Artigo
Language:	Inglês
Published:	Nature Publishing Group 2003
Subjects:	Clinical
Online Access:	https://ncbi.nlm.nih.gov/pmc/articles/PMC2741048/ https://ncbi.nlm.nih.gov/pubmed/12778059 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6600915
Tags:	Add Tag No Tags, Be the first to tag this record!

Immunotherapy with concurrent subcutaneous GM-CSF, low-dose IL-2 and IFN-α in patients with progressive metastatic renal cell carcinoma

Similar Items